These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21314678)

  • 1. Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine.
    Bockbrader HN; Burger P; Knapp L
    Epilepsia; 2011 Feb; 52(2):405-9. PubMed ID: 21314678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
    Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
    Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):105-15. PubMed ID: 23205518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.
    Bockbrader HN; Burger P; Knapp L; Corrigan BW
    Epilepsia; 2011 Feb; 52(2):248-57. PubMed ID: 21269291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticonvulsant drugs.
    Stefan H; Feuerstein TJ
    Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
    Gil-Nagel Rein A; Gómez-Alonso J
    Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin in partial epilepsy.
    Beydoun A; Nasreddine W; Atweh S
    Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed?
    Bourgeois BF
    Neurology; 2000; 55(11 Suppl 3):S11-6. PubMed ID: 11147563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Dudra-Jastrzebska M; Andres-Mach M; Czuczwar SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):18-25. PubMed ID: 19751793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic drug interactions in children taking oxcarbazepine.
    Sallas WM; Milosavljev S; D'souza J; Hossain M
    Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis.
    Luszczki JJ; Antkiewicz-Michaluk L; Raszewski G; Czuczwar SJ
    Epilepsy Res; 2010 May; 89(2-3):207-19. PubMed ID: 20117917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.
    Grasela TH; Fiedler-Kelly J; Cox E; Womble GP; Risner ME; Chen C
    J Clin Pharmacol; 1999 Apr; 39(4):373-84. PubMed ID: 10197296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
    Patsalos PN
    Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication.
    May TW; Rambeck B; Neb R; Jürgens U
    Ther Drug Monit; 2007 Dec; 29(6):789-94. PubMed ID: 18043477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.